← All Sponsors
SPONSOR

Aga Khan University

Total Trials
3
Recruiting
3
Phases
Phase 4, Phase 3

Aga Khan University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Cyanotic Heart Disease, Cardiopulmonary Bypass, ERAS, Newborn Health.

The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Aga Khan University

How many clinical trials has Aga Khan University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Aga Khan University, of which 3 are actively recruiting participants. These trials cover conditions including Cyanotic Heart Disease, Cardiopulmonary Bypass, ERAS. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Aga Khan University research focus on?
Aga Khan University clinical trials span Cyanotic Heart Disease, Cardiopulmonary Bypass, ERAS, Newborn Health, Multiple Micronutrient Deficiencies During Pregnancy, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Aga Khan University clinical trial?
To participate in a Aga Khan University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Aga Khan University trials with current recruitment status updated daily.

Clinical Trials by Aga Khan University

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology